Direct-to-Consumer (DTC)

Direct-to-Consumer (DTC) designates marketing and distribution strategies where pharmaceutical or healthcare companies promote products directly to patients through advertising, digital platforms, or retail channels rather than exclusively targeting healthcare professionals. This commercial approach encompasses television, print, and digital advertising informing consumers about treatment options and encouraging physician consultations, as well as certain products sold directly without prescriptions. DTC practices vary globally, with the United States representing the primary market permitting prescription drug advertising directly to consumers alongside New Zealand.

The pharmaceutical industry employs DTC strategies achieving multiple objectives including raising disease awareness, educating patients about treatment options, destigmatising conditions, driving prescription requests through physician consultations, and building brand recognition. Regulatory frameworks govern DTC advertising content, requiring fair balance between efficacy and risk information and adherence to labelling claims. Digital evolution has transformed DTC through targeted online advertising, social media engagement, disease state websites, and patient support programmes. Critics raise concerns about medicalisation of normal conditions, inappropriate treatment requests, and cost impacts from expensive branded drugs. Supporters argue informed patients participate more actively in healthcare decisions and underdiagnosed conditions receive needed attention. As healthcare consumerism grows and patients increasingly research conditions independently, DTC strategies continue evolving through personalised digital marketing, influencer partnerships, and innovative engagement models balancing commercial objectives with appropriate education.